Hani Katerji

HER2-low breast cancers: incidence, HER2 staining patterns, clinicopathologic features, MammaPrint and BluePrint genomic profiles

Huina Zhang, Hani Katerji, Bradley M. Turner et al. · Modern Pathology · 2022 · 105 citations

Her2-low Breast Cancers, Breast Oncology, Blueprint Genomic Profiles +10

Interobserver and Interantibody Reproducibility of HER2 Immunohistochemical Scoring in an Enriched HER2-Low–Expressing Breast Cancer Cohort

Cansu Karakaş, Haley Tyburski, Bradley M. Turner et al. · American Journal of Clinical Pathology · 2023 · 56 citations · Full text

ZBTB16: a novel sensitive and specific biomarker for yolk sac tumor

Guang‐Qian Xiao, Faqian Li, Pamela D. Unger et al. · Modern Pathology · 2016 · 39 citations · Full text

Specific Biomarker, Tumor Biology, Tumoral Pathology +11

Primary Esophageal Melanoma with Aberrant CD56 Expression: A Potential Diagnostic Pitfall

Hani Katerji, John M. Childs, Laura Bratton et al. · Case Reports in Pathology · 2017 · 12 citations · Full text

Esophageal Cancer, Potential Diagnostic Pitfall, Pathology +16

Biomarker and multigene assay testing in ER positive, HER-2 negative breast carcinomas: An international guidelines-based approach

Bradley M. Turner, Hani Katerji, Huina Zhang et al. · Human Pathology Reports · 2021 · 10 citations · Full text